Year: 2017
Type: editorial
Abstract: This editorial examines Miwa et al's article entitled “Phase 1/2 Study of Immunotherapy With Dendritic Cells Pulsed With Autologous Tumor Lysate in Patients With Refractory Bone and Soft Tissue Sarcoma: A Safe Method for Inducing an Immunological Response but With Limited Effects on Clinical Outcomes,” which appears in the current issue of Cancer. The state of the art of autologous cancer vaccines is briefly reviewed, and suggestions for improved immunological therapy for sarcomas are discussed. See also pages 1576‐84.
Source: Cancer
DOI: 10.1002/cncr.30603
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2593835971